Jove
Visualize
联系我们

相关概念视频

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

46.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Standard Precaution01:26

Standard Precaution

2.0K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.0K
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

534
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
534
Drug Elimination: Non-Renal Routes01:23

Drug Elimination: Non-Renal Routes

2.4K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.4K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

147
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
147

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A retrospective cohort assessing practices of hypoxemia management for inpatients of Rwandan public hospitals.

Discover public health·2026
Same author

Long-term protection following a primary series of hepatitis B vaccine in Alaska Native children and adults.

Hepatology communications·2026
Same author

Essential laboratory tests in emergencies; on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Committee on Preparation of Laboratories for Emergencies (C-PLE).

Clinical chemistry and laboratory medicine·2026
Same author

Primary liver cancer in Georgia: Seven years' experience following the launch of the Hepatitis C Elimination Program, 2015-2022.

PloS one·2026
Same author

Updated hepatitis D seroprevalence among HBsAg-positive persons aged ≥6 years in the United States, National Health and Nutrition Examination Survey, 2007‒2018.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Examining community perspectives on integrated service delivery for tuberculosis, mental health and substance use disorder in Nigeria: A qualitative study.

PloS one·2026
Same journal

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026
Same journal

Lineage dynamics and risk factors underlying serotype 4 invasive pneumococcal disease in Spain.

The Journal of infectious diseases·2026
Same journal

Tuberculosis in pregnancy: Challenges of immune protection.

The Journal of infectious diseases·2026
Same journal

Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study.

The Journal of infectious diseases·2026
Same journal

Authors' Reply: Diagnostic Accuracy of Commercial Large Language Models for Anogenital Skin Lesion Images.

The Journal of infectious diseases·2026
Same journal

Methodological Considerations in Evaluating Large Language Models for Anogenital Lesion Diagnosis.

The Journal of infectious diseases·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 16, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K

从全球C型肝炎消除计划中吸取的教训

Senad Handanagic1, Shaun Shadaker1, Jan Drobeniuc1

  • 1Centers for Disease Control and Prevention, Division of Viral Hepatitis, Atlanta, Georgia, USA.

The Journal of infectious diseases
|September 22, 2023
PubMed
概括
此摘要是机器生成的。

分散和集成模型显著增加了格鲁吉亚,卢旺达和尼日利亚的C型肝炎病毒 (HCV) 测试准入. 这些策略对于实现到2030年全球消除HCV的目标至关重要.

关键词:
乔治亚 乔治亚 乔治亚 乔治亚 乔治亚尼日利亚 尼日利亚 尼日利亚卢旺达卢旺达卢旺达卢旺达卢旺达卢旺达卢旺达卢旺达卢旺达型肝炎C型肝炎的发生病毒性肝炎的消除和消除

更多相关视频

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

11.4K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K

相关实验视频

Last Updated: Jul 16, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

11.4K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K

科学领域:

  • 公共卫生 公共卫生
  • 传染性疾病 传染性疾病
  • 全球健康 全球健康

背景情况:

  • 世界卫生组织制定了2030年消除型肝炎病毒 (HCV) 作为公共卫生威胁的目标.
  • 尽管取得了进展,但在2020年,全球只有23%的HCV感染被诊断出来,这突显了测试和护理准入方面的关键差距.
  • 分散和集成的医疗保健模式为克服检测障碍提供了一个有希望的方法.

研究的目的:

  • 检查去中心化和集成模型如何改善全球卫生计划中对HCV检测的准入.
  • 突出在格鲁吉亚,卢旺达和尼日利亚实施的成功策略,用于HCV检测和与护理联系.
  • 为实现2030年HCV消除目标的未来战略提供信息.

主要方法:

  • 分析格鲁吉亚,卢旺达和尼日利亚的C型肝炎计划数据和策略.
  • 专注于实施去中心化测试和综合服务交付模式.
  • 包括特定的测试技术,如HCV核心抗原和医疗点 (POC) HCVRNA测试.

主要成果:

  • 格鲁吉亚通过简化测试和POC利用实现了高查率 (80%的成年人) 和治疗启动.
  • 卢旺达实现了查目标,并通过迅速分散和整合HCV服务,开始治疗.
  • 尼日利亚的近POC综合测试方法扩大了HCV病毒性检测的访问,使得同一天的测试和治疗启动.

结论:

  • 分散和集成的HCV检测模型有效地增加了获得护理的机会和联系.
  • 在格鲁吉亚,卢旺达和尼日利亚成功实施,为其他旨在消除HCV的国家提供了宝贵的见解.
  • 这些战略对于实现2030年全球型肝炎消除目标至关重要.